Cargando…
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial
As lactoferrin is a nutritional supplement with proven antiviral and immunomodulatory abilities, it may be used to improve the clinical course of COVID-19. The clinical efficacy and safety of bovine lactoferrin were evaluated in the LAC randomized double-blind placebo-controlled trial. A total of 21...
Ejemplares similares
-
Gas6/TAM Axis Involvement in Modulating Inflammation and Fibrosis in COVID-19 Patients
por: Rizzi, Manuela, et al.
Publicado: (2023) -
Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients
por: Tonello, Stelvio, et al.
Publicado: (2022) -
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein
por: Rizzi, Manuela, et al.
Publicado: (2022) -
Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients
por: Tonello, Stelvio, et al.
Publicado: (2023) -
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort
por: Rizzi, Manuela, et al.
Publicado: (2023)